Acromegaly: Update on Management and Long-Term Morbidities
- PMID: 32741483
- DOI: 10.1016/j.ecl.2020.05.007
Acromegaly: Update on Management and Long-Term Morbidities
Abstract
Acromegaly is a systemic disease associated with great morbidity and increased mortality if not adequately treated. In the past decades much improvement has been achieved in its treatment and in the knowledge of its comorbidities. We provide an update of acromegaly management with current recommendations. We also address long-term comorbidities emphasizing the changing face of the disease in more recent series, with a decrease of cardiovascular disease severity and an increased awareness of comorbidities like bone disease, manifested mainly as vertebral fractures and the change in the main cause of death (from cardiovascular disease to cancer in more recent series).
Keywords: Acromegaly; Comorbidities; Pituitary adenoma; Somatotropinoma; Treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure M.R. Gadelha has received unrestricted research grants and lecture fees from Novartis, Ipsen, and Pfizer; has participated on advisory boards for Novartis and Ionis; and is a principal investigator in clinical trials by Novartis and Ipsen. L. Kasuki has received lecture fees from Novartis, Pfizer, and Ipsen and has participated as a coinvestigator in clinical trials by Novartis and Ipsen. The other authors have nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
